Medicofarma Biotech S.A.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2008-08-05
Share capital
6,797,830.00 PLN
Activity description

Medicofarma Biotech is a company listed on NewConnect that focuses on the development of innovative drugs, medical devices, and biotechnology products aimed at preventing and treating lifestyle diseases. It offers research and development services and routine analyses for the pharmaceutical, cosmetic, food, and chemical sectors through its contract laboratory. The company is also involved in projects related to cancer therapies and the creation of plant-based medicinal products.

Registered address
ul. Sokołowska 9/U19, 01-142 Warszawa, Poland
Email
Phone
Electronic delivery address
AE:PL-41110-14874-AFFAU-27

Financials

Revenue history (in k)

Financial insight

  • The statement flags a going concern risk. Opis w nocie nr 8 w informacji dodatkowej.

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 73 days for 2024). All were audited by a statutory auditor.

  • 202514/07/2026
  • 202426/09/2025
  • 202301/08/2024
  • 202203/07/2023
  • 202115/07/2022
  • 202013/08/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Stock quotes

PLN 0.35
-0.02 (-4.84%)
0.320.330.340.350.360.3510:0012:0014:0016:00
Open
PLN 0.36
High
PLN 0.36
Low
PLN 0.32
Volume
15.24K
Avg. vol.
12.41K
Market cap
PLN 24.06M
P/E ratio
–
EPS
-PLN 0.03
Shares outstanding
67.98M
52-week
PLN 0.32 – 0.39
Dividend yield
–
Dividend
–
Ex dividend date
–
Exchange
NewConnect

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD 9.18kUSD -162.34kUSD -162.34k
Q1 2026USD 9.72kUSD -154.78kUSD -155.05k
Q4 2025USD 2.01kUSD 127.83kUSD -28.88k
Q3 2025USD 28.13kUSD -184.58kUSD -184.58k

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 28%
City · Warszawa25,987 / 56,729
Top 46%
Voivodeship · Mazowieckie36,282 / 76,892
Top 47%
Country · Poland144,518 / 297,069
Top 49%

Results vs industry

Revenue
This companyUSD 314.88kMedianUSD 56.72kAverageUSD 2.72m
Net profit
This companyUSD -560.15kMedianUSD -1.27kAverageUSD -93.01k
Operating costs
This companyUSD 702.29kMedianUSD 66.48kAverageUSD 2.68m
Assets
This companyUSD 3.57mMedianUSD 134.71kAverageUSD 3.04m

Authorized Representatives

Cezary Robert Kilczewski age 61 – President of the Management Board

Manner of representation

Each member of the management board has the right to represent the company independently.

Supervisory board

Alicja Jabłońska age 65 – Supervisory Board Member
Krzysztof Józef Berndt age 59 – Supervisory Board Member
Jarosław Bułka age 54 – Supervisory Board Member
Katarzyna Ewa Wiśniewska age 40 – Supervisory Board Member
Marek Kazimierz Lubicz-Nowicki age 75 – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2001-06-01.

  • mBank
    47 1140 1010 0000 2803 0900 1005
  • mBank
    04 1140 1010 0000 2803 0900 1003
  • mBank
    20 1140 1010 0000 2803 0900 1006

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$130.5K
Buildings and premises
$1.1M

Public aid

9 public aid cases recorded, with a total value of $866,075.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$845
Aid for research and development projects: experimental development
$579.1K
Aid for research and development projects: industrial research
$276.3K

Regulatory authorisations

AuthorityTypeStatus
Consumer credit intermediary Active

Competitors

Name
Pikralida sp. z o.o.
Nanogroup S.A.
Bioresearch Group sp. z o.o.
Warmil Tech sp. z o.o.
Ergtech sp. z o.o.
Globe Badania Kliniczne sp. z o.o.
TCI sp. z o.o.
Cofactor sp. z o.o.
Medesto sp. z o.o.
Microblic sp. z o.o.

Change history

DateEvent
2021-09-16Address change
2021-06-25Share capital increase
2021-03-15PKD change
2021-02-01Name change
2017-07-12Address change

FAQ

Last updated: 2026-10-03